Masahiro Teramoto

Nishinomiya-hama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Post-CAR T-cell thyroid dysfunction: destructive thyroiditis identified through thyroid function monitoring in a single-center cohort.

Post-CAR T-cell thyroid dysfunction: destructive thyroiditis identified through thyroid function monitoring in a single-center cohort.

Journal: Frontiers in oncology

Published: May 09, 2026

Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.

Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.

Journal: Cytotherapy

Published: March 09, 2026

Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.

Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.

Journal: Bone marrow transplantation

Published: February 14, 2025

Impact of Cytokine Release Syndrome on Cardiac Function After Chimeric Antigen Receptor-T Cell Therapy.

Impact of Cytokine Release Syndrome on Cardiac Function After Chimeric Antigen Receptor-T Cell Therapy.

Journal: JACC. Asia

Published: December 29, 2023

Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis.

Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis.

Journal: Annals of hematology

Published: November 03, 2023

Donor-derived cytomegalovirus-specific CD8+ T cells restricted to shared, donor-specific, or host-specific HLA after HLA mismatched hematopoietic stem cell transplantation.

Donor-derived cytomegalovirus-specific CD8+ T cells restricted to shared, donor-specific, or host-specific HLA after HLA mismatched hematopoietic stem cell transplantation.

Journal: Transplant immunology

Published: November 02, 2023

Individualized rabbit anti-thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high-risk hematologic malignancy: Exposure-response analysis and population pharmacokinetics simulations.

Individualized rabbit anti-thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high-risk hematologic malignancy: Exposure-response analysis and population pharmacokinetics simulations.

Journal: American journal of hematology

Published: June 29, 2023

Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy.

Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy.

Journal: Clinical pharmacokinetics

Published: April 10, 2023

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation.

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation.

Journal: International journal of hematology

Published: December 15, 2021

The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis.

The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis.

Journal: Acta haematologica

Published: August 24, 2021

Spontaneous resolution of refractory ascites in the late phase after cord blood transplantation in acute myeloid leukemia

Spontaneous resolution of refractory ascites in the late phase after cord blood transplantation in acute myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 08, 2021

Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study

Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 07, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026